What is the market doing?
What the tape says about TAK
Takeda Pharmaceutical Company Limited is +27% over the past year while the S&P 500 is +23%: 4.5 points ahead of the market.
+27%
1-year return · S&P 500 +23%
- vs 200-day average
- +11%
vs 200-day average · a clear uptrend
- RSI (14)
- 73
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −2.9%
Below its 52-week high
Details›
- Last close2026-08-26
- $18.25
- 1 monthS&P 500 +3.7%
- +8.4%
- 1 yearS&P 500 +23%
- +27%
- 5 yearsS&P 500 +87%
- +16%
- vs 50-day average$16.67
- +9.4%
- 52-week high
- $18.80
- 52-week low
- $13.23
- Annualised volatility
- 21%
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +20% |
| 2024 | −3.1% |
| 2023 | −8.5% |
| 2022 | +14% |
| 2021 | −25% |
| 2020 | −7.8% |
| 2019 | +17% |
| 2018 | −41% |
| 2017 | +37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 8 of 10 | +3.9% |
| Feb | 10 | 5 of 10 | +1.1% |
| Mar | 10 | 5 of 10 | −1.1% |
| Apr | 10 | 5 of 10 | −1.9% |
| May | 10 | 4 of 10 | −0.65% |
| Jun | 10 | 3 of 10 | −0.87% |
| Jul | 11 | 7 of 11 | +1.8% |
| Aug | 11 | 7 of 11 | +1.3% |
| Sep | 10 | 4 of 10 | −0.26% |
| Oct | 10 | 3 of 10 | −4.9% |
| Nov | 10 | 5 of 10 | +2.3% |
| Dec | 10 | 7 of 10 | +0.62% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #14 of 28 by Smart Score